231 related articles for article (PubMed ID: 34657306)
1. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.
Nakayama T; Miyabe S; Okabe M; Sakuma H; Ijichi K; Hasegawa Y; Nagatsuka H; Shimozato K; Inagaki H
Mod Pathol; 2009 Dec; 22(12):1575-81. PubMed ID: 19749740
[TBL] [Abstract][Full Text] [Related]
3. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
[TBL] [Abstract][Full Text] [Related]
6. Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping.
Fehr A; Werenicz S; Trocchi P; Falk M; Friedrich RE; Stammler A; Stang A; Oesterling F; Khil L; Stenman G; Böcker W; Tiemann K; Löning T
Virchows Arch; 2021 Nov; 479(5):975-985. PubMed ID: 34231055
[TBL] [Abstract][Full Text] [Related]
7. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
[TBL] [Abstract][Full Text] [Related]
8. MAML2 Rearrangements in Variant Forms of Mucoepidermoid Carcinoma: Ancillary Diagnostic Testing for the Ciliated and Warthin-like Variants.
Bishop JA; Cowan ML; Shum CH; Westra WH
Am J Surg Pathol; 2018 Jan; 42(1):130-136. PubMed ID: 28877061
[TBL] [Abstract][Full Text] [Related]
9. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
[TBL] [Abstract][Full Text] [Related]
10. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
[TBL] [Abstract][Full Text] [Related]
11. Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions.
Skálová A; Agaimy A; Stanowska O; Baneckova M; Ptáková N; Ardighieri L; Nicolai P; Lombardi D; Durzynska M; Corcione L; Laco J; Koshyk O; Žalud R; Michal M; Vanecek T; Leivo I
Am J Surg Pathol; 2020 Dec; 44(12):1612-1622. PubMed ID: 33002921
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma.
Noda H; Okumura Y; Nakayama T; Miyabe S; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Cancer Sci; 2013 Jan; 104(1):85-92. PubMed ID: 23035786
[TBL] [Abstract][Full Text] [Related]
13. Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2- rearranged salivary gland tumours.
Bishop JA; Thompson LDR; Siegele B; Gagan J; Mansour M; Chernock RD; Rooper LM
Histopathology; 2023 Jan; 82(2):305-313. PubMed ID: 36208053
[TBL] [Abstract][Full Text] [Related]
14. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis.
Cipriani NA; Lusardi JJ; McElherne J; Pearson AT; Olivas AD; Fitzpatrick C; Lingen MW; Blair EA
Am J Surg Pathol; 2019 Jul; 43(7):885-897. PubMed ID: 31021855
[TBL] [Abstract][Full Text] [Related]
15. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
[TBL] [Abstract][Full Text] [Related]
16. CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.
Skálová A; Vanecek T; Simpson RH; Vazmitsel MA; Majewska H; Mukensnabl P; Hauer L; Andrle P; Hosticka L; Grossmann P; Michal M
Am J Surg Pathol; 2013 Nov; 37(11):1743-50. PubMed ID: 24121173
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
[TBL] [Abstract][Full Text] [Related]
18. Thymic Mucoepidermoid Carcinoma: A Clinicopathologic and Molecular Study.
Murase T; Nakano S; Sakane T; Domen H; Chiyo M; Nagasaka S; Tanaka M; Kawahara Y; Toishi M; Tanaka T; Nakamura S; Sawabata N; Okami J; Mukaida H; Tzankov A; Szolkowska M; Porubsky S; Marx A; Roden AC; Inagaki H
Am J Surg Pathol; 2022 Aug; 46(8):1160-1169. PubMed ID: 35319525
[TBL] [Abstract][Full Text] [Related]
19. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
Saade RE; Bell D; Garcia J; Roberts D; Weber R
JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
[TBL] [Abstract][Full Text] [Related]
20. Primary mucoepidermoid carcinoma of the external auditory canal with a CRTC1::MAML2 fusion: A case report and a review of literature.
De la Sancha C; Kuhar M; Kraft A; Alomari AK
J Cutan Pathol; 2023 Nov; 50(11):947-950. PubMed ID: 37394842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
